The transfer of multigene panel testing for hereditary breast and ovarian cancer to healthcare: What are the implications for the management of patients and families?-Reference-Cited by-同舟云学术

The transfer of multigene panel testing for hereditary breast and ovarian cancer to healthcare: What are the implications for the management of patients and families?

Published:2016-10-15 Issue:2 Volume:8 Page:1957-1971
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Eliade Marie¹,Skrzypski Jeremy²,Baurand Amandine¹²,Jacquot Caroline¹²,Bertolone Geoffrey¹²,Loustalot Catherine³,Coutant Charles³⁴,Guy France⁵,Fumoleau Pierre⁶⁴,Duffourd Yannis⁷,Arnould Laurent⁸,Delignette Alexandra⁹,Padéano Marie-Martine³,Lepage Côme¹⁰¹¹,Raichon-Patru Géraldine¹²,Boudrant Axelle¹³,Bône-Lépinoy Marie-Christine¹⁴,Villing Anne-Laure¹⁵,Charpin Aurélie¹,Peignaux Karine¹⁶,Chevrier Sandy¹⁷,Vegran Frédérique¹⁷,Ghiringhelli François⁶¹⁷,Boidot Romain¹⁷,Sevenet Nicolas¹⁸,Lizard Sarab⁸,Faivre Laurence¹²

Affiliation:

1. Centre of Genetic, Children Hospital, CHU, Dijon, France

2. Oncogenetic Unit, Centre Georges-François Leclerc Centre, Dijon, France

3. Gynecological Surgery, Georges-François Leclerc Centre, Dijon, France

4. Burgundy Franche-Comté University, Dijon, France

5. Radiology unit, Georges-François Leclerc Centre, Dijon, France

6. Medical Oncology, Georges-François Leclerc Centre, Dijon, France

7. Orphanomix, Dijon, France

8. Biology and Tumor Pathology Department, Georges-François Leclerc Centre, Dijon, France

9. Elithis Tower, Radiology, Dijon, France

10. Hepato-Gastroenterology and Digestive Oncology, François Mitterand Hospital, CHU, Dijon, France

11. Burgundy Franche-Comté University, INSERM LNC UMR866, Dijon, France